Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Medical Technology
  • Page 8
novocure-device-fails-to-improve-brain-cancer-patients’-survival-in-phase-3-test
Posted inMedical Technology

Novocure device fails to improve brain cancer patients’ survival in phase 3 test

June 18, 2026
Novocure’s tumor-treating electric fields device missed its primary endpoint in a late-stage glioblastoma trial.  The Swiss medtech’s product has an…
Read More
fda-clears-dexcom’s-stelo-otc-glucose-monitor-for-use-with-children
Posted inMedical Technology

FDA clears Dexcom’s Stelo OTC glucose monitor for use with children

June 16, 2026
The FDA has given the green light to Dexcom’s popular over-the-counter glucose monitor Stelo for children two years or older…
Read More
irhythm-hit-by-cyberattack-that-compromised-patient-data,-says-operations-unaffected
Posted inMedical Technology

iRhythm hit by cyberattack that compromised patient data, says operations unaffected

June 16, 2026
Medical device maker iRhythm has been hit by a cyberattack, but the company said the incident has not affected its…
Read More
amid-us-investment-tour,-j&j-makes-$1b-stop-in-florida-to-upgrade-contact-lens-plant
Posted inMedical Technology

Amid US investment tour, J&J makes $1B stop in Florida to upgrade contact lens plant

June 15, 2026
With Johnson & Johnson gradually fleshing out its $55 billion U.S. investment scheme in recent months, the New Jersey-headquartered drug…
Read More
guardant-health-nabs-fda-test-approval-to-find-patients-for-boehringer’s-new-cancer-drug
Posted inMedical Technology

Guardant Health nabs FDA test approval to find patients for Boehringer’s new cancer drug

June 12, 2026
Boehringer Ingelheim’s Hernexeos has nabbed a companion diagnostic from Guardant Health after the FDA cleared its liquid biopsy test, Guardant360…
Read More
roche-nabs-eu-approval-on-label-expansions-for-companion-dx-platform
Posted inMedical Technology

Roche nabs EU approval on label expansions for companion dx platform

June 11, 2026
Roche has received approval through the EU’s In Vitro diagnostic regulation for several label expansions of its companion diagnostic platform…
Read More
predicta-links-with-spanish-university-to-offer-diagnostic-for-blood-cancers
Posted inMedical Technology

Predicta links with Spanish university to offer diagnostic for blood cancers

June 11, 2026
Predicta Biosciences, a precision oncology specialist, is teaming with the Clínica Universidad de Navarra’s CIMA Lab Diagnostics clinic to offer…
Read More
galmed-acquires-colospan-in-$4.5m-deal-as-it-eyes-$6b-gi-dx-market
Posted inMedical Technology

Galmed acquires Colospan in $4.5M deal as it eyes $6B GI dx market

June 9, 2026
Galmed Pharmaceuticals acquired Colospan in a $4.5 million deal as the Israel-based biotech looks to create a gastrointestinal platform targeting…
Read More
roche-sticks-with-e600m-diagnostics-investment-in-germany-but-warns-of-future-risk
Posted inMedical Technology

Roche sticks with €600M diagnostics investment in Germany but warns of future risk

June 9, 2026
As news hit last week that Eli Lilly and Boehringer Ingelheim are cutting investments in Germany, Roche said it will…
Read More
cequr-nabs-$100m-series-e-to-fuel-insulin-patch-commercialization
Posted inMedical Technology

CeQur nabs $100M series E to fuel insulin patch commercialization

June 9, 2026
Swiss medtech CeQur has raised $100 million in a new series E funding round for what it called its “most…
Read More

Posts pagination

Previous page 1 … 6 7 8 9 10 … 53 Next page

Privacy Policy    Terms

Scroll to Top